|
Indian Pediatr 2015;52: 31 -33 |
|
Risk Factors Associated with Methicillin-resistant
Staphylococcus aureus Infection in Children
|
Kandasamy Senthilkumar, Niranjan Biswal and *Sujatha
Sistla
From Departments of Pediatrics and *Microbiology,
Jawaharlal Institute of Postgraduate Medical Education and Research
(JIPMER), Pondicherry, India.
Correspondence: Dr Niranjan Biswal, Professor,
Department of Pediatrics, JIPMER, Pondicherry-605006, India.
Email: [email protected]
Received: April 22, 2014;
Initial review: June 10, 2014;
Accepted: November 10, 2014.
|
Objective: To identify the clinical variables
that differentiate MRSA (Methicillin-resistant Staphylococcus aureus)
from MSSA (Methicillin-sensitive S. aureus) infection. Methods:
Cases having culture isolates of Staphylococcus species were
recruited. Baseline and other laboratory parameters were compared
between MSSA and MRSA sub-groups to identify the predictors for MRSA.
Results: Out of 98 isolates of S.aureus, 46 (47%) were MRSA.
Significant leukocytosis was found in cases with MRSA (P <0.03).
None of the other clinical variables could differentiate MRSA from MSSA
infection. Conclusion: Presence of leukocytosis was twice more
likely to predict MRSA than MSSA at admission. Empiric therapy must be
guided by antimicrobial sensitivity pattern of regional culture
isolates.
Keywords: MRSA, Risk factors.
|
Methicillin-resistant Staphylococcus aureus
(MRSA) is a common multidrug resistant pathogen worldwide [1]. Emergence
of community-associated MRSA (CA-MRSA) infections has a fundamentally
different epidemiology compared to that of hospital-associated MRSA
(HA-MRSA) infections [2]. CA-MRSA infections often do not have previous
health care exposure and commonly manifests as skin and soft-tissue
infections [3]. There is a paucity of data on childhood MRSA infection
in developing countries. Knowledge on its prevalence and risk factors
may help to plan the preventive strategies.
Methods
This study was done in the Department of Pediatrics
and Microbiology, JIPMER, Pondicherry, India (August 2011 to July 2013)
after obtaining clearance from the Institute Ethics Committee.
The primary objective was to identify clinical
variables that could differentiate MRSA and MSSA (Methicillin-sensitive
Staphylococcus aureus) infection in children (0-12 years) treated
with confirmed Staphylococcus infections. Isolates were
identified as S.aureus using standard microbiological methodology
from blood, pus, urine, CSF (cerebrospinal fluid) and pleural fluid.
Oxacillin screen agar was used to detect methicillin resistance in
Mueller Hinton Agar supple-mented with 6 µg/mL of Oxacillin sodium and
4% NaCl as per Clinical and Laboratory Standards Institute
recommendations [4]. Control strains used in this study were ATCC 29213
for MSSA and ATCC 43300 for MRSA.
Informed consent was taken from the parents. Baseline
demographic data was recorded. Details of prior hospitalization and
antibiotic usage within 12 months, history of exanthematous illness like
measles and varicella, abrasion/laceration, contact with potential
S.aureus carrier, malnutrition, and immunosuppressant usage were
recorded. Specimens were collected at admission from all the patients
except from those with hospital-acquired S.aureus infection.
Children with confirmed S.aureus infection were classified into
MSSA and MRSA subgroups. Cases with a previous history of
hospitalization, septic shock, tricuspid valve endocarditis and pyogenic
arthritis were suspected to have MRSA infection. MRSA was further
classified into CA-MRSA and HA-MRSA subgroups. All the cases were
followed up till discharge or death.
A case was classified as Hospital-onset if the MRSA
culture was obtained on or after the fourth calendar day of
hospitalization, where admission is hospital day 1; as
healthcare-associated community-onset (HACO) if the culture was obtained
in an outpatient setting or before the fourth calendar day of
hospitalization and had one of more of the following: (i) a
history of hospitalization, surgery, dialysis, or residence in a long
term care facility in the previous year, or (ii) the presence of
a central vascular catheter within 2 days prior to MRSA culture; and as
Community-associated (CA), if none of the previously mentioned criteria
were met [4].
Anemia was defined as reduction of the hemoglobin
concentration below the range for age and sex [6]. Leukocytosis was
defined as white blood cell (WBC) count >2 SD above the mean for age
[7], and thrombocytopenia as platelet count <1,50,000/cu mm [8]. Sepsis:
Systemic Inflammatory Response Syndrome (SIRS) associated with suspected
or proven infection (by positive culture, tissue stain, or polymerase
chain reaction test) as per International Pediatric Sepsis consensus
conference guidelines [7].
Results
Out of 210 patients screened, 98 isolates were
S.aureus. Out of 98 isolates of S.aureus, 52 (53%) were MSSA.
Thirty seven (80%) isolates of MRSA were community acquired and 9 (20%)
were hospital acquired. MRSA occurrence among skin and soft tissue
infections (SSTI), empyema, and bacteremia were 44%, 66%, 30%,
respectively. Demographic variables were comparable in both the groups.
Associated risk factors for possible S.aureus infection could be
identified in 49% of the study population (Table I). There
was no significant difference in the number of children with PEM between
MRSA and MSSA subgroup.
TABLE I Comparison of Risk Factors in Age Group of > 1 Month* – 12 Years
Risk Factors |
Methicillin-resistant S.aureus |
Methicillin-sensitive S.aureus |
OR |
|
n=35 |
n=43 |
(95% CI) |
|
No(%) |
No(%) |
|
Hospitalization in prior 12 mo |
6 (17) |
5 (12) |
1.57 (0.43-5.66) |
Exanthematous illness (fever with rash) in prior 12 mo
|
4 (11) |
2 (5) |
2.64 (0.43-21.5) |
History of minor truma causing skin discontinuity |
5 (14) |
6 (14) |
1.03 (0.28-3.69) |
Antibiotic usage in prior 12 mo |
6 (17) |
8 (19) |
0.91 (0.28-2.90) |
Immunosuppressant usage |
1 (3) |
2 (5) |
0.6 (0.01-6.90) |
Contact with potential S. aureus infected patient |
0 (0) |
2 (5) |
– |
*Risk factors are not applicable in ≤1
month; P>0.05 for all comparisons. |
Proportion of cases with leukocytosis were
significantly higher in the MRSA than MSSA (P< 0.03) (Table II).
Susceptibility of MRSA to vancomycin was 100% and to clindamycin was
63%. Eight strains of MRSA and six strains of MSSA had inducible
clindamycin resistance detected by D test. Clindamycin resistance in
SSTIs was 25%. Cases with MRSA infection stayed 4.8 days longer in
hospital than the MSSA. Case fatality was similar in both the groups
(MRSA= 7%, MSSA= 4%; P=0.883).
TABLE II Comparison of Laboratory Values and Clinical Course During Hospital Stay
Variables |
MRSA |
MSSA |
OR |
P value |
|
n=46 |
n=52 |
(95% CI) |
|
Anaemia |
13 (28) |
18 (35) |
0.74 (0.29-1.91) |
0.50 |
Leukocytosis |
35 (76) |
29 (56) |
2.52 (1.06-6.30) |
0.04 |
Thrombocytopenia |
2 (4) |
4 (8) |
0.79 (0.04-4.04) |
0.80 |
Septic shock |
6 (13) |
7 (14) |
0.96 (0.26-3.55) |
0.95 |
Needed ICU stay |
5 (11) |
7 (14) |
0.78 (0.20-3.05) |
0.70 |
Requring mechanical ventilation |
5 (11) |
7 (14) |
0.78 (0.20 -3.05) |
0.70 |
MRSA: Methicillin-resistant S. aureus; MSSA: Methicillion –
susceptible S. aureus; Values in No (%). |
Discussion
SSTI were the predominant sites for both MRSA (42%)
and MSSA (46%) followed by blood stream infection, similar to another
study from India [9]. Clinical variables were not different between MRSA
and MSSA subgroups. None of the clinical variables could predict MRSA
infection at admission like other studies [10,11].
Though nearly half of the cases with MSSA had
leukocytosis, significant leucocytosis was most often associated with
MRSA infection. Presence of leukocytosis in staphylococcal bone and
joint infections was an excellent predictor of MRSA in two other studies
[12,13].
Following an uniform antibiotic policy of
administering cloxacillin to all the suspected staphylococcal infection,
antibiotic change to vancomycin was needed in 67% of cases who later
grew MRSA. Among very sick children treated with vancomycin for
suspected MRSA, switching over to cloxacillin was needed in 23% as they
grew MSSA. Hence, severity of clinical condition at admission may not be
a useful indicator to initiate empiric antibiotic therapy for MRSA.
Convenience sampling was used in this study. Culture
isolation was performed at a single tertiary center; therefore, the
findings may not be extrapolated to other areas where circulating strain
types may differ. Multicentric studies with a larger population
involving community may be needed to validate these findings.
Differentiation between CA-MRSA and HA-MRSA was based on epidemiological
factors alone and not on molecular analysis of SCC mecs, which is the
gold standard.
Risk factors being similar in MRSA and MSSA
infections, standard hygienic measures and proper treatment guidelines
would be beneficial in controlling both MRSA and MSSA. Empiric
antibiotics for suspected staphylococcal infection must be guided by
frequently analyzing the hospital culture isolates and sensitivity
pattern rather than relying on clinical variables and pointers in the
history.
Contributors: KS and NB: were involved in
designing the study and management of the patients; KS: collected the
data and reviewed the literature. NB conceptualized the study, reviewed
the literature and critically reviewed the manuscript; SS: provided
guidance regarding laboratory evaluation and also critically reviewed
the manuscript. All authors contributed to drafting of the manuscript
and approved the final version of the manuscript.
Funding: None; Competing interest: None
stated.
What This Study Adds?
•
Clinical and epidemiologic characteristics cannot
distinguish MRSA from MSSA infection.
•
It is twice more likely
to isolate MRSA rather than MSSA from a child when total
leukocyte count is elevated (2SD for age).
|
References
1. Cosgrove SE, Fowler VG Jr. Management of
methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis.
2008;46:S386-93.
2. Boucher HW, Corey GR. Epidemiology of methicillin-resistant
Staphylococcus aureus. Clin Infect Dis. 2008;46:S344-9.
3. Stryjewski ME, Chambers HF. Skin and soft-tissue
infections caused by community-acquired methicillin-resistant
Staphylococcus aureus. Clin Infect Dis. 2008;46:S368-77.
4. Clinical and Laboratory Standards Institute. 2013.
Performance standards for Antimicrobial susceptibility testing; twenty
third Informational supplement. M100-S23. Accessed September 24, 2014.
5. Centers for Disease Control and Prevention. 2011.
Active Bacterial Core Surveillance Report, Emerging Infections Program
Network, Methicillin-Resistant Staphylococcus aureus, 2011. Available
from: http://www.cdc.gov/abcs/reportsfindings/survreports/mrsa11.
Accessed September 23, 2014.
6. Lerner Norma B. The anaemia. In: Kliegman
RM, Stanton BF, St.Geme JW, Schor NF, Behrman RE. Nelson Textbook of
Pediatrics. 19th ed. Philadelphia,: Elsevier; 2011.p.1648.
7. Goldstein B, Giroir B, Randolph A, International
Consensus Conference on Pediatric Sepsis. International pediatric sepsis
consensus conference: definitions for sepsis and organ dysfunction in
pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
8. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach
H, Opal SM, et al. Surviving Sepsis Campaign: international
guidelines for management of severe sepsis and septic shock, 2012.
Intensive Care Med. 2013;39:165-228.
9. Joshi S, Ray P, Manchanda V, Bajaj J, Chitinis DS,
Gautam V, et al. Methicillin resistant Staphylococcus aureus
(MRSA) in India: Prevalence and susceptibility pattern. Indian J Med
Res. 2013;137:363-9.
10. Golding GR, Levett PN, McDonald RR, Irvine J,
Nsungu M, Woods S, et al. A comparison of risk factors associated
with community-associated methicillin-resistant and -susceptible
Staphylococcus aureus infections in remote communities. Epidemiol
Infect. 2010;138:730-7.
11. Miller LG, Perdreau-Remington F, Bayer AS, Diep
B, Tan N, Bharadwa K, et al. Clinical and epidemiologic
characteristics cannot distinguish community-associated methicillin-resistant
Staphylococcus aureus infection from methicillin-susceptible S. aureus
infection: a prospective investigation. Clin Infect Dis. 2007;44:471-82.
12. Kini AR, Shetty V, Kumar AM, Shetty SM, Shetty A.
Community-associated, methicillin-susceptible, and methicillin-resistant
Staphylococcus aureus bone and joint infections in children: experience
from India. J Pediatr Orthop Part B. 2013;22:158-66.
13. Ju KL, Zurakowski D, Kocher MS. Differentiating
between methicillin-resistant and methicillin-sensitive Staphylococcus
aureus osteomyelitis in children: an evidence-based clinical prediction
algorithm. J Bone Joint Surg Am. 2011;93:1693-701.
|
|
|
|